ALK+ ALCL EVADES IMMUNE SURVEILLANCE THROUGH NPM-ALK-DRIVEN EPIGENETIC REPRESSION OF Cd48. (October 2022) - Wu, R.; Sahasrabuddhe, A.; Ivan, E.; Shaw, T.; Mullighan, C.; Leventaki, V.; Elenitoba-Johnson, K.; Lim, M.